US Stock MarketDetailed Quotes
HSDTW HELIUS MEDICAL TECHNOLOGIES INC C/WTS 02/02/2026 (TO PUR COM)
- 0.001
- 0.0000.00%
15min DelayClose Nov 12 16:00 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.001Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.00152wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM0Shs Float0.001Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
HELIUS MEDICAL TECHNOLOGIES INC C/WTS 02/02/2026 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -13.01%-2.77M | -5.51%-2.89M | 5.92%-3M | 27.21%-10.42M | 5.09%-2.03M | 35.83%-2.45M | 25.22%-2.74M | 31.87%-3.19M | -6.89%-14.31M | 38.12%-2.14M |
| Net income from continuing operations | -0.63%-3.69M | 2.18%-1.61M | -0.88%-2.52M | 37.11%-8.85M | 78.61%-1.05M | -255.63%-3.66M | 56.75%-1.65M | 42.61%-2.49M | 22.39%-14.07M | -19.11%-4.89M |
| Operating gains losses | -158.16%-335K | -7.49%-1.59M | 29.77%-854K | -42.57%-3.25M | -149.11%-1.13M | 112.14%576K | -492.06%-1.48M | -460.37%-1.22M | -32,485.71%-2.28M | 12,010.53%2.3M |
| Depreciation and amortization | -61.90%16K | -66.67%16K | -68.63%16K | -36.47%162K | -47.50%21K | -40.85%42K | -33.33%48K | -29.17%51K | -18.27%255K | -46.67%40K |
| Other non cash items | -15.38%11K | -23.08%10K | -16.67%10K | -38.82%52K | 7.69%14K | 8.33%13K | -51.85%13K | -63.64%12K | 3.66%85K | -63.89%13K |
| Change In working capital | -712.50%-147K | 17.17%-82K | -175.00%-39K | 76.19%-311K | -336.07%-288K | 107.29%24K | 79.07%-99K | 108.31%52K | -1,128.35%-1.31M | -21.79%122K |
| -Change in receivables | 138.60%136K | -395.00%-99K | -59.09%72K | -182.52%-291K | -313.11%-504K | 267.65%57K | -147.62%-20K | 1,500.00%176K | -10,400.00%-103K | -144.00%-122K |
| -Change in inventory | -91.67%4K | -1,058.70%-441K | 428.57%92K | 223.42%137K | 607.14%71K | 245.45%48K | 342.11%46K | 37.78%-28K | -27.59%-111K | -122.58%-14K |
| -Change in prepaid assets | 440.00%135K | -19.16%135K | -8.40%120K | 115.25%54K | 47.56%-269K | -92.06%25K | 345.59%167K | 248.86%131K | -178.74%-354K | -755.00%-513K |
| -Change in payables and accrued expense | -387.80%-400K | 228.73%345K | -43.13%-302K | 78.42%-123K | -44.06%438K | 85.54%-82K | 35.42%-268K | 43.13%-211K | -201.24%-570K | 136.56%783K |
| -Change in other current liabilities | 14.29%-12K | 15.38%-11K | 15.38%-11K | -20.45%-53K | 0.00%-13K | -16.67%-14K | 0.00%-13K | -116.67%-13K | 30.16%-44K | 18.75%-13K |
| -Change in other working capital | 0.00%-10K | 0.00%-11K | -233.33%-10K | 71.77%-35K | -1,200.00%-11K | -600.00%-10K | ---11K | 97.64%-3K | 22.50%-124K | 100.90%1K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -13.01%-2.77M | -5.51%-2.89M | 5.92%-3M | 27.21%-10.42M | 5.09%-2.03M | 35.83%-2.45M | 25.22%-2.74M | 31.87%-3.19M | -6.89%-14.31M | 38.12%-2.14M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 73.68%-5K | -163.64%-29K | -250.00%-3K | 14.29%-6K | 90.00%-1K | -575.00%-19K | 80.36%-11K | 140.00%2K |
| Net PPE purchase and sale | --0 | --0 | 73.68%-5K | -163.64%-29K | -250.00%-3K | 14.29%-6K | 90.00%-1K | -575.00%-19K | 79.63%-11K | 140.00%2K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 73.68%-5K | -163.64%-29K | -250.00%-3K | 14.29%-6K | 90.00%-1K | -575.00%-19K | 80.36%-11K | 140.00%2K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -132.75%-149K | 5.64M | 1.46M | -93.97%1.08M | 622K | -97.36%455K | 0 | 0 | -15.42%17.87M | 0 |
| Net common stock issuance | --0 | --1.59M | --1.37M | -97.32%500K | --216K | -98.42%284K | --0 | --0 | -17.85%18.64M | --0 |
| Cash dividends paid | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | -99.52%1K | --4.83M | --162K | --642K | --435K | --207K | --0 | --0 | --0 | --0 |
| Net other financing activities | ---150K | ---808K | ---42K | 91.61%-65K | ---29K | ---- | ---- | ---- | 73.17%-775K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -132.75%-149K | --5.64M | --1.46M | -93.97%1.08M | --622K | -97.36%455K | --0 | --0 | -15.42%17.87M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -25.72%6.39M | -67.92%3.64M | -64.38%5.18M | 32.20%14.55M | -60.47%6.6M | 162.73%8.6M | 79.71%11.34M | 32.20%14.55M | 230.38%11.01M | 255.06%16.69M |
| Current changes in cash | -45.78%-2.92M | 200.29%2.75M | 51.92%-1.54M | -364.04%-9.37M | 33.91%-1.42M | -114.92%-2M | 9.75%-2.74M | 31.65%-3.21M | -53.81%3.55M | -133.96%-2.14M |
| Effect of exchange rate changes | --1K | --0 | ---1K | 125.00%1K | -50.00%1K | --0 | --0 | --0 | 50.00%-4K | --2K |
| End cash Position | -47.42%3.47M | -25.72%6.39M | -67.92%3.64M | -64.38%5.18M | -64.38%5.18M | -60.47%6.6M | 162.73%8.6M | 79.71%11.34M | 32.20%14.55M | 32.20%14.55M |
| Free cash flow | -12.73%-2.77M | -5.47%-2.89M | 6.33%-3.01M | 27.10%-10.45M | 4.86%-2.04M | 35.79%-2.46M | 25.39%-2.74M | 31.49%-3.21M | -6.57%-14.33M | 38.26%-2.14M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data